We have solutions for Pharma and Biotech
Heligenics is disrupting and redefining the way genetic information is used in the creation of new drugs at multiple steps along the drug development pipeline. Use our GMLs pre-clinically to minimize adverse events and non-responders before an expensive clinical trial. Our super-precision genetic-based trial design increases safety and efficacy, producing desired outcomes for all phases of a clinical trial.
Redesign a failed clinical trial into a targeted precision trial. Repurpose a drug to maximize profits with our receptor activation maps to experimentally identify off-target receptors and new indications.